Co-Design of a Digital Health Tool for Use by Individuals With Opioid Use Disorder: App4Independence (A4i-O).

co-design digital health interventions health technology opioid use disorder

Journal

Substance use & addiction journal
ISSN: 2976-7350
Titre abrégé: Subst Use Addctn J
Pays: United States
ID NLM: 9918750589006676

Informations de publication

Date de publication:
30 Jul 2024
Historique:
medline: 30 7 2024
pubmed: 30 7 2024
entrez: 30 7 2024
Statut: aheadofprint

Résumé

Opioid use disorder (OUD) has arguably the highest mortality rate of mental health conditions; opiate-related deaths are identified as the number one cause of accidental deaths in Canada and the United States. Specialized care for OUD is often described as lacking, fractured, and with frequent periods of disengagement. Digital health strategies may support connection to evidence-based resources even during periods of disengagement. However, sustained engagement in digital interventions remains a barrier, and as such, experts recommend using co-design approaches to develop interventions. The current study outlines the results from a qualitative co-design project that engaged 6 lived experts and 8 clinical experts in a series of focus groups and interviews to adapt an existing intervention for use in OUD. Focus groups and interviews were recorded and transcribed before undergoing thematic analysis. This co-design process is the first stage of a larger project that will lead to the development of a novel digital health intervention for OUD populations. Transcripts underwent thematic analysis, and themes were divided into Crosscutting Themes, Feasibility and Engagement, and Specific Features. Each theme was divided into specific subthemes, which were reviewed by the design team and informed the design of the digital health platform. Key resulting directions included creating a psychologically safe digital space, curating resources for OUD as a multifaceted condition, and being mindful of barriers to implementation from both lived and clinical expert perspectives. Specific features are discussed in detail in the article. Lived experts and clinicians strongly supported integrating digital tools into OUD care. Ongoing work is needed to better understand the role of technology in existing OUD structures as well as the implementation of key features such as digital peer support and creating effective and safe social connections. This study also validates co-design as an essential step in digital health development.

Sections du résumé

BACKGROUND UNASSIGNED
Opioid use disorder (OUD) has arguably the highest mortality rate of mental health conditions; opiate-related deaths are identified as the number one cause of accidental deaths in Canada and the United States. Specialized care for OUD is often described as lacking, fractured, and with frequent periods of disengagement. Digital health strategies may support connection to evidence-based resources even during periods of disengagement. However, sustained engagement in digital interventions remains a barrier, and as such, experts recommend using co-design approaches to develop interventions.
METHODS UNASSIGNED
The current study outlines the results from a qualitative co-design project that engaged 6 lived experts and 8 clinical experts in a series of focus groups and interviews to adapt an existing intervention for use in OUD. Focus groups and interviews were recorded and transcribed before undergoing thematic analysis. This co-design process is the first stage of a larger project that will lead to the development of a novel digital health intervention for OUD populations.
RESULTS UNASSIGNED
Transcripts underwent thematic analysis, and themes were divided into Crosscutting Themes, Feasibility and Engagement, and Specific Features. Each theme was divided into specific subthemes, which were reviewed by the design team and informed the design of the digital health platform. Key resulting directions included creating a psychologically safe digital space, curating resources for OUD as a multifaceted condition, and being mindful of barriers to implementation from both lived and clinical expert perspectives. Specific features are discussed in detail in the article.
CONCLUSION UNASSIGNED
Lived experts and clinicians strongly supported integrating digital tools into OUD care. Ongoing work is needed to better understand the role of technology in existing OUD structures as well as the implementation of key features such as digital peer support and creating effective and safe social connections. This study also validates co-design as an essential step in digital health development.

Identifiants

pubmed: 39077962
doi: 10.1177/29767342241258915
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29767342241258915

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The technology behind the core architecture of the platform, A4i Schizophrenia, was developed and owned by the joint for-profit venture A4i. The company Memotext owns 50% of this company, the Centre for Addiction and Mental Health owns 35% of this company, and Dr Sean A. Kidd owns 15% of this company. COI has been reviewed by legal professionals, and a mitigation plan has been implemented.

Auteurs

Jessica N D'Arcey (JN)

Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, ON, Canada.

Leah Tackaberry-Giddens (L)

Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Sana Junaid (S)

Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, ON, Canada.
Memotext, Toronto, ON, Canada.

Wenjia Zhou (W)

Memotext, Toronto, ON, Canada.

Lena Quilty (L)

Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, ON, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Matthew Sloan (M)

Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, ON, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Addictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Division of Neurosciences and Clinical Translation, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Sean A Kidd (SA)

Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Classifications MeSH